Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
62.22 EUR | -1.86% |
|
+2.82% | -7.31% |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.31% | 8.74B | - | ||
-11.94% | 1.31B | B+ | ||
-3.59% | 1.2B | - | ||
-30.41% | 748M | - | - | |
-.--% | 619M | - | - | |
+6.99% | 475M | - | ||
+2.38% | 433M | - | - | |
-34.41% | 294M | - | - | |
-63.28% | 265M | - | ||
+1.00% | 218M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- HS2 Stock
- Ratings Henry Schein, Inc.